Ghost Tree Capital’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-50,000
Closed -$2.96M 58
2021
Q3
$2.96M Sell
50,000
-135,000
-73% -$10.6M 0.98% 43
2021
Q2
$16.1M Hold
185,000
5.02% 4
2021
Q1
$15.3M Buy
185,000
+20,000
+12% +$1.92M 4.27% 8
2020
Q4
$15M Sell
165,000
-35,000
-18% -$2.17M 3.73% 11
2020
Q3
$7.99M Buy
200,000
+75,000
+60% +$2.62M 2.7% 15
2020
Q2
$4.29M Sell
125,000
-100,000
-44% -$2.98M 1.41% 29
2020
Q1
$5M Sell
225,000
-50,000
-18% -$1.26M 2.21% 18
2019
Q4
$5.38M Sell
275,000
-75,000
-21% -$1.19M 1.45% 31
2019
Q3
$5.44M Buy
+350,000
New +$6.71M 1.89% 23
2018
Q4
Sell
-75,000
Closed -$1.22M 49
2018
Q3
$1.22M Buy
+75,000
New +$887K 0.32% 48
2015
Q4
Sell
-89,231
Closed -$476K 59
2015
Q3
$476K Buy
+89,231
New +$609K 0.24% 66

Other funds holding FATE